Ms
Hsu
Min Chung

Partner & Patent Attorney

London Office Oxford Office

Telephone. +44(0) 207 776 5100
Email. [email protected]

Experience

Hsu Min specialises in patents in the fields of chemistry, material science and pharmaceuticals. Her experience includes drafting and prosecuting patent applications in a wide range of technologies, including those relating to pharmaceuticals, catalytic processes, household products, electrochemistry, medical devices and polymers.

Hsu Min has a wealth of experience in European Oppositions and Appeals and regularly represents clients at Oral proceedings at the European Patent Office. She manages substantial patent portfolios and regularly provides clients with opinions on their freedom-to-operate in the light of third party rights. She works for a variety of clients including universities, start-ups and multi-national corporations.

Hsu Min has a First Class Masters’ Degree in Chemistry from Oxford University. She started in the patent profession in private practice in 1996, before joining the in-house patent department of a FTSE 100 multinational Oil & Gas company. She joined HGF as a Partner in 2011, having been a Partner at another major patent firm.

Specialisms

  • Catalysis
  • Electrochemistry
  • Food science
  • Household products
  • Material science
  • Pharmaceutical technologies
  • Polymer chemistry
  • Printing technologies

Industries

  • CleanTech icon CleanTech
  • Food & drink icon Food & drink
  • Healthcare icon Healthcare
  • Pharmaceuticals icon Pharmaceuticals

Services

  • Due diligence
  • Patent oppositions & appeals
  • Patents
  • Portfolio management
  • Strategy

Qualifications

Patent Attorney

Chartered (UK)
European


MCHEM

First Class Masters' Degree in Chemistry (University of Oxford)

Recognition

IAM 1000 - The World's Leading Patent Professionals

IAM Strategy 300 - The World's Leading IP Strategists

Publications

IAM Strategy 300 2020

View publication online

IAM Patent 1000 2020

View publication online

UK - Billion pound support package for innovative firms hit by coronavirus

View publication online

IAM Patent 1000 2019

View publication online

UK - Billion pound support package for innovative firms hit by coronavirus

View publication online

Conferences: 2021

January 14th 2021

HGF IP in Healthcare Virtual Conference 2021

Speaker

Event details

Conferences: 2020

September 21st 2020

2020 IPO Annual Meeting

Attended

Event details

March 3rd 2020

IP in Healthcare Conference 2020

Speaker

Event details

Conferences: 1970

January 1st 1970

Speaker

CSR

Hsu Min has given seminars about various aspects of intellectual property to students and academics at her local university. For example, she has presented at Fellowship Programmes for Entrepreneurs.

Related News

Managing Intellectual Property IP Stars & Firm Rankings 2021

Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed. IP STARS is the leading …

Read article

Medical technology most patented subject matter at EPO in 2020

Pharmaceutical and biotechnology patent applications also make top 10 most patented. Recent statistics published by the EPO show that a total of 14,295 European patent applications were filed in 2020 …

Read article

The EPO ‘How To’ guide for antibody applications in Europe

The 2021 EPO Guidelines provide much needed guidance on how to protect antibodies in Europe. Biological drugs including therapeutic antibodies have become increasingly important to the pharmaceutical industry. The European …

Read article

Personalised drug patenting in Europe

Opportunities for additional pharmaceutical product patent protection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Recent years have …

Read article

The Internet of Medical Things

Exploring the growth of patents for connected medical devices, and how best to protect them. The Internet of Things (IoT) is expected to change our lives by creating a connected …

Read article

Covid-19 vaccine patent waivers

To waive, or not to waive, that is the question. The earliest identified date of a patient presenting with symptoms of a “novel coronavirus” in Wuhan, China is reported to …

Read article

G1/21 hearing at the EPO

Follow this page for the updates from G1/21 hearing at the EPO on 28th May 2021. HGF Partners Dr Chris Moore and Douglas Drysdale will be reporting all the key …

Read article
Event - 9th June 2021

Webinar: Developing effective patent strategies for personalised medical devices in Europe and the US

HGF in Europe and Knobbe Martens in the US are holding a joint webinar on 9th June. In this webinar we will explore considerations for implementing an effective strategy to …

Event details

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.